ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 85 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,090 | -28.8% | 56,976 | 0.0% | 0.44% | +81.9% |
| Q2 2023 | $368,065 | -14.3% | 56,976 | 0.0% | 0.24% | -20.3% |
| Q1 2023 | $429,599 | -25.6% | 56,976 | 0.0% | 0.30% | -84.9% |
| Q4 2022 | $577,167 | +2.5% | 56,976 | 0.0% | 2.02% | +8.9% |
| Q3 2022 | $563,000 | -7.2% | 56,976 | 0.0% | 1.85% | +24.5% |
| Q2 2022 | $607,000 | +55.2% | 56,976 | +42.1% | 1.49% | +120.6% |
| Q1 2022 | $391,000 | -26.6% | 40,091 | +7.6% | 0.67% | +11.6% |
| Q4 2021 | $533,000 | -13.5% | 37,264 | +21.3% | 0.60% | -6.1% |
| Q3 2021 | $616,000 | +11.6% | 30,719 | +22.4% | 0.64% | +2.1% |
| Q2 2021 | $552,000 | -16.1% | 25,107 | +29.6% | 0.63% | -27.9% |
| Q1 2021 | $658,000 | +82.8% | 19,372 | +116.8% | 0.87% | +76.6% |
| Q4 2020 | $360,000 | – | 8,936 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |